FR2796551B1 - Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant - Google Patents

Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant

Info

Publication number
FR2796551B1
FR2796551B1 FR9909614A FR9909614A FR2796551B1 FR 2796551 B1 FR2796551 B1 FR 2796551B1 FR 9909614 A FR9909614 A FR 9909614A FR 9909614 A FR9909614 A FR 9909614A FR 2796551 B1 FR2796551 B1 FR 2796551B1
Authority
FR
France
Prior art keywords
same
pharmaceutical compositions
compositions containing
obtaining
metformin salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9909614A
Other languages
English (en)
Other versions
FR2796551A1 (fr
Inventor
Gerard Moinet
Daniel Cravo
Gerard Botton
Didier Mesangeau
Lilianne Doare
Micheline Kergoat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
LIPHA Liyonnaise Industrielle Pharmaceutique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS, LIPHA Liyonnaise Industrielle Pharmaceutique filed Critical LIPHA SAS
Priority to FR9909614A priority Critical patent/FR2796551B1/fr
Publication of FR2796551A1 publication Critical patent/FR2796551A1/fr
Application granted granted Critical
Publication of FR2796551B1 publication Critical patent/FR2796551B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9909614A 1999-07-23 1999-07-23 Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant Expired - Fee Related FR2796551B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9909614A FR2796551B1 (fr) 1999-07-23 1999-07-23 Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9909614A FR2796551B1 (fr) 1999-07-23 1999-07-23 Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant

Publications (2)

Publication Number Publication Date
FR2796551A1 FR2796551A1 (fr) 2001-01-26
FR2796551B1 true FR2796551B1 (fr) 2003-07-25

Family

ID=9548471

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9909614A Expired - Fee Related FR2796551B1 (fr) 1999-07-23 1999-07-23 Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant

Country Status (1)

Country Link
FR (1) FR2796551B1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10166246B2 (en) 2014-05-27 2019-01-01 City Of Hope TGR5 agonist complexes for treating diabetes and cancer
US10988471B2 (en) 2014-07-29 2021-04-27 Shenzhen Hightide Biopharmaceutical, Ltd. Pharmaceutical composition comprising berberine ursodeoxycholic acid salt for the treatment of various diseases or disorders

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818908B1 (fr) * 2000-12-29 2004-04-02 Dospharma Utilisation en tant que medicament d'un compose restituant in vivo des principes actifs
FR2818906B1 (fr) 2000-12-29 2004-04-02 Dospharma Association medicamenteuse d'une biguanine et d'un transporteur, par exemple de metformine et d'arginine
DE10318045A1 (de) * 2003-04-17 2004-11-04 Basf Ag Stabile Ammoniumsalze der alpha-Liponsäure, ihre Herstellung und Verwendung
CN101522658A (zh) 2006-06-16 2009-09-02 因迪基恩药物公司 作为抗糖尿病药用于控制糖尿病高血糖症和糖尿病并发症的二甲双胍r-(+)硫辛酸盐
AR065670A1 (es) 2007-03-09 2009-06-24 Indigene Pharmaceuticals Inc Combinacion de metformina r-(+) lipoato y agentes antihiperlipidemicos para el tratamiento de hiperglucemia diabetica y complicaciones diabeticas
US20110021634A1 (en) 2009-06-18 2011-01-27 Patel Pranav Dushyant Processes for preparing metformin hydrochloride
WO2011025271A2 (fr) * 2009-08-25 2011-03-03 한올바이오파마주식회사 Ascorbate de metformine, procédé de préparation correspondant, composition pharmaceutique le comprenant et formulation combiné le comprenant
WO2017195086A1 (fr) * 2016-05-10 2017-11-16 Sarath Kumar Kamavarapu Sels de n, n-diméthylbiguanide et procédés de préparation associés
CN114349665B (zh) * 2021-11-30 2023-06-09 潍坊博创国际生物医药研究院 二甲双胍焦谷氨酸晶体及其制备方法与应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7116M (fr) * 1968-01-08 1969-07-15
FR2037002A1 (en) * 1969-04-30 1970-12-31 Roques Bernard N-substd biguanide pamoic acid salts prepn
FR2220256A1 (en) * 1973-03-09 1974-10-04 Nouvel Lucien 1,1'-Dialkyl-biguanide theophyllin-7-acetates - with hypocholesterolaemic and hypolipamic activity
AT323195B (de) * 1973-03-16 1975-06-25 Hurka Wilhelm Verfahren zur herstellung neuer salze von biguaniden
AT325632B (de) * 1973-06-01 1975-10-27 Hurka Wilhelm Verfahren zur herstellung von nicotinsauren salzen von derivaten des biguanids
FR2243684B1 (fr) * 1973-09-19 1977-01-28 Semb
FR2264539A1 (en) * 1974-03-22 1975-10-17 Expl Marques Brevets Et Metformin orotate - hypoglycemic, hypocholesterolemic and uricosuric agent
FR2264525B1 (fr) * 1974-03-22 1977-11-04 Expl Marques Brevets Et
FR2275199A1 (fr) * 1974-06-19 1976-01-16 Cerpha (chloro-4 phenoxy) isobutyrate de dimethylbiguanide, son procede de preparation et medicaments contenant ce produit comme principe actif
RO82052A2 (fr) * 1981-05-22 1983-07-07 Institutul De Cercetari Chimico-Farmaceutice,Ro Sels des acides aryloxyalkylcarboxyliques-sulfamides avec n,n-dimethylbiguanide et procede de preparation
FR2611500B1 (fr) * 1987-03-06 1990-05-04 Lipha Emploi de derives du biguanide dans la preparation de medicaments
EP1004304A4 (fr) * 1996-12-24 2002-10-16 Sumitomo Pharma Composition contenant de l'acide ascorbique
EP1039890B1 (fr) * 1997-12-08 2004-03-17 Bristol-Myers Squibb Company Sels de metformine et procede
FR2774591B1 (fr) * 1998-02-12 2000-05-05 Lipha Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10166246B2 (en) 2014-05-27 2019-01-01 City Of Hope TGR5 agonist complexes for treating diabetes and cancer
US10988471B2 (en) 2014-07-29 2021-04-27 Shenzhen Hightide Biopharmaceutical, Ltd. Pharmaceutical composition comprising berberine ursodeoxycholic acid salt for the treatment of various diseases or disorders
US11685735B2 (en) 2014-07-29 2023-06-27 Shenzhen Hightide Biopharmaceutical, Ltd. Pharmaceutical composition comprising berberine salts for the treatment of various diseases or disorders

Also Published As

Publication number Publication date
FR2796551A1 (fr) 2001-01-26

Similar Documents

Publication Publication Date Title
MA26622A1 (fr) Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26680A1 (fr) Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26630A1 (fr) 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2816938B1 (fr) Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
MA26687A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2789079B3 (fr) Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
MA24832A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydropyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant
MA26675A1 (fr) Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26471A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26558A1 (fr) Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2796940B1 (fr) Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
MA24529A1 (fr) Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions les contenant .
MA26571A1 (fr) Derives d'acide hydroxamique, compositions pharmaceutiques les contenant et procede pour leur preparation
FR2827604B1 (fr) Nouveaux derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2- one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
MA26620A1 (fr) Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA24469A1 (fr) Derives d'acide arylsulfonyhydroxamique, procede pour leur preparation et compositions les contenant
MA26654A1 (fr) Pyrrolopyrimidines nouvelles procede pour leur preparation et compositions pharmaceutiques les contenant
MA26743A1 (fr) Composes nouveaux inhibiteurs de metalloproteases, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26588A1 (fr) Derives d'erythromycine nouveaux, procede et intermediaires pour leur preparation, et compositions pharmaceutiques les contenant
MA26669A1 (fr) 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26505A1 (fr) Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2810320B1 (fr) Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
MA26707A1 (fr) Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26501A1 (fr) Derives de quinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2796551B1 (fr) Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant

Legal Events

Date Code Title Description
CD Change of name or company name
CJ Change in legal form
ST Notification of lapse

Effective date: 20060331